Risk Factors for Pancreatic Neuroendocrine Tumors

Pancreas - United States
doi 10.1097/mpa.0000000000000234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Pancreatic Neuroendocrine Tumors

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2017English

Promising Developments for Pancreatic Neuroendocrine Tumors

Cancer Discovery
Oncology
2011English

Expression of Transcription Factors in MEN1-associated Pancreatic Neuroendocrine Tumors

Endocrinology, Diabetes and Metabolism Case Reports
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

The Risk of Recurrence in Grade 2 Pancreatic Neuroendocrine Tumors

HPB
HepatologyGastroenterology
2018English

Outcomes After Surgery for Malignant Pancreatic Neuroendocrine Tumors

Kurdistan Journal of Applied Research
2019English

Outcomes After Surgery for Malignant Pancreatic Neuroendocrine Tumors

Kurdistan Journal of Applied Research
2019English

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors

Cancers
Cancer ResearchOncology
2010English

Sunitinib in Pancreatic Neuroendocrine Tumors. Clinical Case

Medical Council
2019English

Small Pancreatic Neuroendocrine Tumors: Resect or Enucleate?

HPB
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy